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Abstract 
Background Atubular glomeruli have been identified in a number of chronic renal 
diseases and have been linked to declining renal function. In type 1 diabetes they are 
present predominantly in proteinuric patients. We investigated the prevalence of 
atubular glomeruli in type 2 diabetes and their relationship to renal function. 
Methods Renal biopsies from 12 type 2 diabetic patients with nephropathy were 
processed for light and electron microscopy and analysed using standard stereological 
techniques. Abnormalities at the glomerular tubular junction were quantified using an 
index of junctional atrophy (IJA). 
Results There was no relationship between the degree of proteinuria and the presence 
of atubular glomeruli or atrophic tubules. Creatinine clearance correlated with the IJA 
(r = - 0.70, p = 0.011), percent sclerosed glomeruli (r = - 0.59, p = 0.027), and 
interstitial volume fraction (r = - 0.54, p = 0.037). The IJA also correlated with foot 
process width and volume fraction interstitium (r = 0.58, p = 0.049 for both). Percent 
sclerosed glomeruli correlated with mesangial (r = 0.65, p = 0.012) and interstitial (r = 
0.69, p = 0.007) volume fractions. 
Conclusions In contrast to type 1 diabetes, atubular glomeruli and atrophic tubules 
occur in type 2 diabetic patients with low levels of proteinuria; their development may 
influence progressive change in GFR. Both glomerular and interstitial damage may 
lead to the development of atubular glomeruli in type 2 diabetic nephropathy. 
Keywords: Diabetic glomerulopathy, glomerular filtration rate, morphology, 
proteinuria. 
Summary: Atubular glomeruli occur in type 2 diabetic patients with nephropathy but 
their presence is not related to the level of proteinuria. Both glomerular and interstitial 
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lesions appear likely to contribute to the decline in GFR by leading to the 
development of non-functioning glomeruli. 
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Introduction 
The relationship between renal structure and function in diabetic patients has been 
described in a number of previous studies (1-4). It is well established that the 
characteristic lesions of diabetic nephropathy - mesangial expansion and thickening of 
the glomerular basement membrane (GBM) – correlate with the level of proteinuria. 
Decline in GFR can be partly explained by the loss of filtration surface that 
accompanies mesangial expansion (5, 6), but only approximately 33% of GFR 
variability can be explained by changes in this structural parameter (7). This is due to 
the fact that GFR must depend upon the total available glomerular filtration surface, a 
parameter that is difficult to determine accurately in diabetic patients as it requires an 
estimate of the total number of functioning glomeruli. Another factor that influences 
glomerular filtration is hydraulic permeability, which decreases with increased GBM 
thickness and decreased filtration slit frequency (8).  
Atubular glomeruli, which are likely to be non-functioning, have been described in a 
number of different renal diseases, including type 1 diabetes (9-12). In type 1 
diabetes, atubular glomeruli and other glomerulotubular junction abnormalities 
(GTJA) were essentially restricted to patients with overt proteinuria, and were 
negatively correlated with GFR (11, 13). We are unaware of any published data on 
atubular glomeruli in type 2 diabetes. 
The aim of our study was to determine the prevalence of atubular glomeruli and other 
GTJAs in a group of type 2 diabetic patients with nephropathy and explore their 
relationship with GFR. 
Subjects and Methods 
The type 2 diabetic patients were part of a previous study assessing the effects of 
perindopril on renal structure and were recruited between 1990 and 1991 (14). 
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Patients were eligible if they had type 2 diabetes according to the criteria of the 
National Diabetes Data Group (15) and if they were between 25 and 65 years old.  
Patients less than 40 years old were required to have a known duration of diabetes of 
at least two years and not require insulin for the first two years.  
All studies were performed in accordance with the guidelines proposed in the 
Declaration of Helsinki. Approval was obtained from local independent review bodies 
and informed signed consent was obtained from each patient. 
There was a 3-month pre-inclusion period to control glycaemia and blood pressure. 
Blood pressure had to be controlled to a target of <160/85 mmHg without the use of 
ACE inhibitors or calcium channel blockers; the α-blocker prazosin was used 
preferentially with or without diuretics. 
At the end of the pre-inclusion period, a percutaneous renal biopsy was performed and 
examined by one of us (RWB) and a pathologist to confirm diabetic 
glomerulosclerosis. To be included, biopsies had to show characteristic lesions of 
diabetic glomerulopathy – GBM thickening, diffuse mesangial expansion and/or 
classic Kimmelstiel-Wilson nodules. All Type 2 patients with ischemic nephropathy 
without any histological characteristics of diabetic glomerulopathy were excluded.  
The identification of atubular glomeruli requires serial sectioning of at least 6 
glomeruli. Only 12 patients who had sufficient biopsy material for determination of 
atubular glomeruli were included in this present study. There were no clinical 
differences between these patients and the whole cohort of 22 patients. The total 
biopsy series examined by light microscopy, and a cohort of patients examined by 
electron microscopy have been described elsewhere (14, 16). All of the patients were 
receiving anti-hypertensive treatment and 7 were receiving insulin therapy. Data 
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presented here are from biopsies performed at the start of the study, prior to 
randomisation and before any patient commenced perindopril. 
Biopsy material was available from 10 non-diabetic kidney donors at time of 
transplantation (mean age 38 years, 5 male). 
Clinical measurements 
The clinical methods have been reported previously (14). Briefly, blood pressure was 
measured as the average of three readings taken one minute apart using a calibrated 
mercury sphygmomanometer. All urine passed during a 24-hour period was collected 
for creatinine clearance (ClCr) and urine protein excretion. Creatinine concentration 
was assessed by a colorimetric method using picric acid. Urine protein concentration 
was determined by a colorimetric method using pyrogallol red. 
Laboratory methods 
For light microscopy, renal biopsies were fixed in Dubosq-Brazil fixative and 
embedded in paraffin. For electron microscopy, small pieces of tissue were fixed in 
2% glutaraldehyde, post-fixed in osmium tetroxide, dehydrated in acetone and 
embedded in epoxy resin.  
Light microscopy 
One micron serial sections were taken through the block and stained with toluidine 
blue for light microscopy. The glomerulotubular junction (GTJ) was identified in each 
glomerulus and scored as normal (0), atrophic tubule (1), or atubular (2) (17). The 
index of junctional atrophy (IJA) was calculated as the average score of at least 6 
glomeruli (11). An atrophic tubule was defined as having flattened epithelium with no 
brush border and thickened tubular basement membrane. This could occur over just a 
few cells or a long segment of the proximal tubule (Figure 1B). The presence of tuft 
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adhesions at the GTJ was noted (Figure 1C). An atubular glomerulus was defined as 
having no tubular connection (Figure 1D).  
Light microscopy was also used to estimate mean glomerular volume (MGV), volume 
fraction of interstitium, and percent sclerosed glomeruli. For determination of MGV, a 
grid of points was superimposed on the toluidine blue sections, 20µm apart, and 
points landing on the glomerulus (defined by the minimal string polygon enclosing 
the glomerular tuft (18)) were counted at a magnification of x360. Using the Cavalieri 
principle (19), MGV is calculated as:  
 MGV = total points * t * area per point, where t = section thickness. 
Volume fraction of interstitium was estimated by point counting on paraffin sections 
stained with Masson’s trichrome (14). The percentage of sclerosed glomeruli was 
estimated from both paraffin and resin embedded tissue in order to increase sample 
size. A glomerulus was considered sclerosed when no open capillary loops were 
observed. The number of sclerosed glomeruli was expressed as a percentage of the 
total number of glomeruli, and at least 15 glomeruli per biopsy had to be counted for 
the measurement to be considered valid (range 16 – 100; mean 49). 
Electron microscopy 
 Morphometric measurements were made on a single glomerular profile from 5 
glomeruli per biopsy. Electron micrographs of the entire profile were printed at a final 
magnification of x2000. Mesangial volume fraction was estimated by point counting 
using a test grid of coarse to fine points in a ratio 1:8. Filtration surface density was 
estimated by counting intersections between test lines and capillary loops (20), 
multiplying this parameter by glomerular volume gives filtration surface per 
glomerulus.  
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Higher magnification micrographs (final print x10,000) were taken by systematic 
random sampling of the glomerular tuft area. These were used to estimate GBM width 
by the orthogonal intercept method (21, 22), and podocyte foot process width (FPW) 
from the ratio of surface density to slit length density (4, 23).  
Statistical analyses 
Values for proteinuria were not normally distributed and were logarithmically 
transformed. Analysis was carried out using SPSS 11.0. Comparisons between groups 
were performed using Student’s t-test or ANOVA for multiple comparisons. 
Relationships between parameters were analysed using Pearson’s correlation 
coefficient. Stepwise linear regression was performed using creatinine clearance as 
the outcome variable. An adjusted R2 was used due to the large numbers of predictors 
in the model. A two-tailed p value < 0.05 was considered statistically significant. 
Results 
The clinical and structural characteristics of the 12 patients are shown in Table 1. The 
patients have also been divided into those with proteinuria above and below 
500mg/24hr, as diabetic patients with proteinuria above 500mg/24hr are classified on 
a clinical basis as having overt nephropathy. There were no differences between 
patients based on their level of proteinuria. 
Nine of the 12 biopsies contained some glomeruli with atrophic tubules and five 
patients had atubular glomeruli. All six of the patients with proteinuria below 
500mg/24hr had some glomeruli with atrophic tubules, and 3 had atubular glomeruli 
(Table 2). Of all the glomeruli examined in the diabetic patients, 26% had GTJAs and 
7% were atubular. In contrast, of the glomeruli examined in the normal biopsies, 9% 
had GTJAs and none were atubular. Sixty-eight percent of glomeruli with atrophic 
tubules had tuft adhesions in the area of the GTJ (Table 2) (Figure 1C). In this region 
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there was thickening and reduplication of the Bowman’s capsule with amorphous 
material between the layers. In 6 of the 9 patients with GTJAs there were some 
glomeruli with capillaries containing foam cells at the adhesion site. Atubular 
glomeruli had thickened Bowman’s capsule in the region where the GTJ would be 
expected to be (opposite the vascular pole) (Figure 1D). All atubular glomeruli had 
tuft adhesions but only 57% appeared to be in the region of the GTJ, although the 
precise location of the GTJ is difficult to determine. 
 The structural characteristics of atubular glomeruli were compared to functioning 
glomeruli within the same biopsies. The results are shown in Table 3. Atubular 
glomeruli were significantly smaller than functioning glomeruli in the same biopsy 
(Figure 2). There were no differences in mesangial volume fraction, GBM width or 
FPW between atubular and functioning glomeruli in the same biopsy. Filtration 
surface per glomerulus was non-significantly reduced in atubular glomeruli in the 
same biopsy, partly as a result of their smaller size. 
Comparing atubular glomeruli with functioning glomeruli from biopsies that 
contained no atubular glomeruli gave similar results i.e. reduced glomerular volume 
and corresponding reduction in filtration surface but no differences in other structural 
parameters (Table 3).  
There was no significant relationship between proteinuria and IJA (Figure 3). The 
patient with the lowest proteinuria (73mg/24hr) had 11% of glomeruli with atrophic 
tubules. Creatinine clearance correlated with IJA (r = - 0.70, p = 0.011), percent 
sclerosed glomeruli (r = - 0.59, p = 0.027), and interstitial volume fraction (r = - 0.54, 
p = 0.037). The IJA also correlated with FPW and volume fraction interstitium (r = 
0.58, p = 0.049 for both). Percent sclerosed glomeruli correlated with mesangial (r = 
0.65, p = 0.012) and interstitial (r = 0.69, p = 0.007) volume fractions. 
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Stepwise linear regression analysis showed that IJA, percent sclerosed glomeruli, 
mesangial volume fraction and FPW were independent predictors of ClCr with a 
combined Ra2 = 0.90, p = 0.001 (Table 4). 
Discussion 
It has previously been suggested that atubular glomeruli and GTJAs in type 1 diabetic 
patients are a result of podocyte damage, and are therefore predominantly found in 
patients with clinical proteinuria (11). In this study we have shown that there is no 
relationship between atubular glomeruli and the level of proteinuria in type 2 diabetic 
patients. This does not rule out proteinuria as a contributory factor in the development 
of GTJAs. The degree of proteinuria required for the development of these lesions 
may simply be lower than that seen in our patients, who mostly had levels 
>300mg/24hr. In support of this, atubular glomeruli were observed in one patient with 
total proteinuria of only 120mg/24hr.  
The lack of a relationship between proteinuria and GTJA might suggest that some 
patients could have proteinuria with few or no glomerular lesions. However, all 
biopsies had characteristic features of diabetic glomerulopathy and there was a direct 
correlation between mesangial volume fraction and proteinuria (data not shown) – a 
well-recognised relationship in diabetic nephropathy.  
The formation of atubular glomeruli could occur in two ways depending on the 
primary disease process. Atubular glomeruli have been reported in several, mainly 
tubulointerstitial diseases in which tubular atrophy and interstitial fibrosis result in the 
glomerulus losing its connection with the proximal tubule (17). The remaining 
atubular glomeruli were reported to have open capillaries and minor ultrastructural 
changes, though were generally smaller than those glomeruli attached to normal 
tubules.  
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A primary glomerular disease could also lead to atubular glomeruli via tuft adhesions, 
perhaps secondary to podocyte loss, and glomerulosclerosis. In this case the atubular 
glomerulus would be expected to have more extensive ultrastructural damage. 
In our study, we confirmed that atubular glomeruli were significantly smaller than 
glomeruli attached to normal tubules in the same biopsy. The atubular glomeruli were 
all structurally abnormal, with typical diabetic lesions. However, the lesions were no 
worse in the atubular glomeruli than in glomeruli with atrophic or normal tubules. 
This might suggest that the predominant cause of atubular glomeruli in these patients 
was tubular-interstitial damage. 
However, we also found that IJA correlated both with the volume fraction of 
interstitium and podocyte FPW. Widening of foot processes can occur in response to 
podocyte loss, which we have reported previously in this group of type 2 patients 
(24). Extensive podocyte loss will eventually lead to denuded areas of GBM and it is 
at these points that tuft adhesions might occur. If atrophic tubules and tuft adhesions 
at the GTJ are a precursor of atubular glomeruli, this suggests that both glomerular 
and interstitial factors are involved in their development.  
It is difficult to compare the results in our type 2 patients directly with those 
previously reported in type 1 diabetes (11) in which atubular glomeruli and GTJAs 
were essentially restricted to proteinuric patients. It should be noted that in the type 1 
study proteinuria was measured on multiple 24h urine collections compared to one 
24h collection in our patients. The IJA is based on only a few glomeruli and could 
therefore be a quite variable index. In addition, equal weighting is given to normal, 
atrophic tubules and atubular glomeruli, when it is possible that these do not develop 
and progress in a linear fashion. Factors such as age and duration may have an 
influence on the prevalence of GTJAs. In type 2 diabetes there are often more 
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advanced tubulointerstitial lesions (25), which could result in the development of 
atubular glomeruli at an earlier stage of nephropathy. The patients in this study were 
being treated for hypertension and therefore hypertension-related changes cannot be 
ruled out as a factor in the development of atubular glomeruli. Arteriolar hyalinosis 
was evident in some glomeruli, although this was not quantified. The study by 
Najafian et al (11) suggested that overt proteinuria might induce new mechanisms of 
nephron injury – our data would suggest that the lesions can occur before overt 
proteinuria develops. 
Biopsy material from diabetic patients is difficult to obtain and the number of 
glomeruli suitable for analysis is often low. The type 1 study by Najafian et al 
included 16 patients and looked at similar numbers of glomeruli per patient. 
Examining more glomeruli or more patients could reveal relationships that we have 
missed. However, the fact remains that even in this small group of patients there are 
atubular glomeruli and GTJ abnormalities in patients without overt proteinuria. 
Atubular glomeruli and atrophic tubules appear to influence creatinine clearance. 
Multiple linear regression analysis showed that the IJA was an independent predictor 
of ClCr. Combined with other structural parameters known to have a detrimental 
effect on renal function the model explained 90% of the ClCr variability. This 
suggests a degree of interplay between different structural parameters that together 
can influence ClCr, and by implication GFR.  It should be pointed out that using 4 
predictors with only a small number of cases could result in an overestimation of the 
predictability value. Using an adjusted r2 is meant to compensate for many predictors 
each “explaining” small portions of the variation by chance, however some over-
fitting of the data cannot be completely ruled out. The results from the linear 
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regression analysis are similar to those reported in type 1 patients, where a model that 
included IJA as an independent predictor explained 92% of GFR variability (11).  
GFR is determined by the total filtration surface area per kidney. Therefore a 
reduction in functioning glomeruli, by glomerulosclerosis or the formation of atubular 
glomeruli, will result in a decline. Percent sclerosed glomeruli correlated with both 
mesangial and interstitial volume fraction, which suggests two routes for glomerular 
occlusion – one from within the glomerulus, and one from without (26). It is likely 
that atubular glomeruli might also develop via these two pathways.  
In conclusion, atubular glomeruli and GTJAs occur in type 2 diabetic patients with 
nephropathy, at both low and high levels of proteinuria, and have a negative 
relationship with GFR. Although interstitial fibrosis is recognised as the final 
common pathway of multiple scarring insults to the kidney, both glomerular and 
interstitial lesions appear likely to contribute to the decline in GFR by leading to the 
development of non-functioning glomeruli. 
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Table 1. Clinical and structural characteristics of 12 type 2 diabetic patients with 
nephropathy. The patients have been divided into those with proteinuria above and 
below 500mg/24hr.  
 All patients 
n = 12 
Proteinuria <500mg/24hr 
n = 6 
Proteinuria ≥500mg/24hr 
n = 6 
Age years 51 (41-64) 49 (41-60) 54 (42-64) 
Proteinuriaa 
mg/24hr 
468 (73-3877) 352 (73-435) 859 (500-3877) 
ClCr ml/min 116 (62-169) 109 (62-169) 124 (88-165) 
Systolic BP 
mmHg 
148 (120-181) 141 (120-157) 155 (135-181) 
Diastolic BP 
mmHg 
86 (70-100) 82 (70-90) 91 (77-100) 
MGV x 106µm3 5.65 ± 1.23 5.58 ± 1.25 5.72 ± 1.33 
VvMes/glom 0.33 ± 0.10 0.31 ± 0.10 0.34 ± 0.11 
Sgbm/glom mm2 0.57 ± 0.23 0.62 ± 0.17 0.52 ± 0.28 
GBM width nm 596 ± 165 550 ± 122 643 ± 291 
FPW nm 828 ± 168 810 ± 1170 846 ± 1180 
VvInt/cortex 0.33 ± 0.05 0.34 ± 0.06 0.32 ± 0.08 
% Scleroseda 12.1 (0-45.5) 9.5 (5.6-45.5) 14.0 (0-28.0) 
IJA 
 
0.43 (0.0-1.0) 0.49 (0.11-0.80) 0.37 (0.0-1.0) 
Data are mean (range), amedian (range), or mean ± sd.  
MGV: mean glomerular volume; VvMes/glom: mesangial volume fraction; Sgbm: 
filtration surface area per glomerulus; GBM: glomerular basement membrane; FPW: 
podocyte foot process width; VvInt/cortex: interstitial volume fraction; IJA: index of 
junctional atrophy. 
There were no significant differences between patients with proteinuria above and 
below 500mg/24hr. 
Table 2. Data on normal glomerulotubular junctions, atrophic tubules and atubular 
glomeruli in 12 type 2 diabetic patients. 
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Patient Proteinuria 
mg/24hr 
No. glomeruli 
with normal 
GTJ 
No. glomeruli 
with atrophic 
tubules 
No. 
atubular 
glomeruli 
No. glomeruli 
with atrophic 
tubules and 
tuft adhesions 
at GTJ 
1 
73 8 1 0 1 
2 
120 7 4 2 3 
3 
300 2 4 0 1 
4 
404 6 2 0 1 
5 
435 5 2 1 0 
6 
435 3 2 1 2 
7 
500 8 0 0 0 
8 
640 2 3 2 3 
9 
857 7 0 0 0 
10 
860 6 0 0 0 
11 
973 6 3 0 3 
12 
3877 2 4 1 3 
GTJ: glomerular tubular junction; IJA: index of junctional atrophy 
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Table 3. Structural characteristics of glomeruli in biopsies with or without atubular 
glomeruli. 
 Biopsies containing atubular 
glomeruli (n=5) 
Biopsies with no 
atubular glomeruli 
(n=7) 
 
 Atubular 
glomeruli  
Functioning 
glomeruli  
Functioning 
glomeruli  
p 
MGV x 106µm3 
 3.35 ± 1.55 6.04 ± 1.05  5.84 ± 1.24 0.016a,b 
VvMes/glom 
 0.37 ± 0.09 0.35 ± 0.14  0.30 ± 0.08 NS 
Sgbm mm2 
 0.27 ± 0.15 0.57 ± 0.28  0.66 ± 0.23 0.035b 
Svgbm/glom mm-1 
 0.08 ± 0.02 0.09 ± 0.05  0.11 ± 0.04 NS 
GBM width nm 
  619 ± 43  573 ± 134   615 ± 157 NS 
FPW nm 1059 ± 274  829 ± 287   849 ± 228 NS 
Data are mean ± sd. 
aAtubular glomeruli compared to functioning glomeruli in same biopsy 
bAtubular glomeruli compared to functioning glomeruli from biopsies with no 
atubular glomeruli. 
MGV: mean glomerular volume; VvMes/glom: mesangial volume fraction; Sgbm: 
filtration surface area per glomerulus; Svgbm/glom: filtration surface density; GBM: 
glomerular basement membrane; FPW: podocyte foot process width. 
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Table 4. Linear regression analysis with creatinine clearance as the dependent variable 
Model R2a p 
IJA 0.47 0.012 
IJA, % Sclerosed glomeruli 0.65 0.006 
IJA, % Sclerosed glomeruli, 
VvMes/glom 
0.79 0.003 
IJA, % Sclerosed glomeruli, 
VvMes/glom, FPW 
0.90 0.001 
IJA: Index of junctional atrophy; VvMes/glom: mesangial volume fraction, FPW: 
podocyte foot process width. 
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Legends to figures 
 
Figure 1. Images of (A) glomerulus with normal tubule (arrow); (B) glomerulus with 
atrophic tubule, note the flattened epithelial cells (arrow); (C) atrophic tubule (AT) 
and tuft adhesion at glomerular tubular junction (arrow); and (D) atubular glomerulus, 
the Bowman’s capsule is thickened at the site opposite the vascular pole where the 
tubule should be (arrow). 
Figure 2. Graph showing mean glomerular volume in type 2 diabetic patients. The 
glomeruli have been divided into atubular and functioning glomeruli from the same 
biopsies, and functioning glomeruli from biopsies that contain no atubular glomeruli. 
Atubular glomeruli are significantly smaller than functioning glomeruli (p = 0.016). 
Symbols  and  represent statistical outliers. 
Figure 3. Graph showing that there is no relationship between the index of junctional 
atrophy and proteinuria in 12 type 2 diabetic patients with nephropathy. Symbol  
represents patients with proteinuria ≥ 500mg/24hr;  represents those with proteinuria 
< 500mg/24hr. 
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